About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Multiple Sclerosis Clinical Trials | 3,733 Studies Recruiting

Clinical TrialsMultiple Sclerosis

Multiple Sclerosis Clinical Trials

Browse 3,733 clinical trials for multiple sclerosis. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1-20 of 3,733 trials

CompletedComparison of Bone Effects With Copaxone and Interferon in Multiple SclerosisThe purpose of this study is to determine if certain drugs commonly used to treat multiple sclerosis have an effect on bone health.NCT00490906·Kansas City, Kansas and 1 other CompletedExamining the Neural Effects of a Behavioral Intervention for Physical Activity in Multiple SclerosisMultiple sclerosis \[MS\] is a prevalent neurological disease that is the leading cause of irreversible neurological disability among young women and the second leading cause of…NCT04496804·Birmingham, Alabama CompletedOcrelizumab Access by Socio-Economic StatusThe primary aim of this project is to determine whether there are differences in access to, efficacy and tolerability of Ocrelizumab in men and women of different racial and…NCT05131984·Boston, Massachusetts

Related Searches

Data from ClinicalTrials.govTerms

RecruitingComprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous SystemInflammatory or degenerative diseases of the brain and spinal cord, such as multiple sclerosis, may be related to problems with an individual s immune system.NCT00794352·Bethesda, Maryland

CompletedCharacteristics, Adherence, and Persistence Among Multiple Sclerosis Patients Treated With Disease-Modifying TherapiesThis retrospective, observational cohort study used administrative claims data contained in the International Business Machines (IBM)® Truven Marketscan® Research Databases to…NCT06459232·East Hanover, New Jersey

UnknownTherapeutic Adherence of Multiple Sclerosis PatientsThe goal of this study is to assess the role of sociocognitive and interpersonal factors in the therapeutic adherence of multiple sclerosis patients.NCT04837352·Bordeaux and 3 others

Not yet recruitingImplementation of Online Mindfulness-Based Stress Reduction Tailored for People with Multiple SclerosisThis project aims to implement and investigate a mindfulness-based stress reduction (MBSR) in people with multiple sclerosis (PwMS).NCT06415552·Toronto

UnknownPatient Acceptable Symptomatic State and Minimal Clinically Important Difference of the Fatigue in Multiple Sclerosis (SeDiF_SEP)Fatigue is the most common symptom and the most disabling symptom of Multiple Sclerosis, and its inefficient management can be a source of multiple consultations (increase in…NCT03662347·Vandœuvre-lès-Nancy

CompletedPhysical Telerehabilitation in Veterans With Multiple SclerosisThe primary objective of this study will be to assess the feasibility and patient acceptance of a Home Automated Telemanagement (HAT) system in multiple sclerosis patients.NCT02346734·Baltimore, Maryland

CompletedImmunological Mechanisms of Hematopoietic Stem Cell Transplantation in Multiple SclerosisOur goal is the elucidation of the mechanisms of action of autologous hematopoietic stem cell transplant (HSCT) and immunoablation by high-dose cyclophosphamide in multiple…NCT00342134·Chicago, Illinois and 1 other

CompletedPhase III Randomized, Double-Blind, Placebo-Controlled Study of Copolymer 1 for Relapsing-Remitting Multiple SclerosisOBJECTIVES: I.NCT00004814

WithdrawnEndeavor™ in Pediatric MSThis study will examine the feasibility of using an Endeavor™ application as a treatment modality for cognitive impairments in the pediatric MS population.NCT04445116·New York, New York

UnknownDesigning Virtual Reality-based Software for People With Multiple SclerosisThe study aims to designing virtual reality-based testing and rehabilitation software for people with multiple sclerosis and assess the feasibility of software.NCT05420532·Izmir

CompletedDual-Task Performance in Patients With Multiple SclerosisMultiple sclerosis (MS) is a chronic inflammatory disease affecting the central nervous system.NCT03508284·Ankara

WithdrawnAlternative Treatment Paradigm for Natalizumab TrialThis study is being done to determine the difference between natalizumab therapy followed by two different withdrawal strategies using Glatiramer Acetate (GA) treatment paradigms…NCT01710228·Dallas, Texas

CompletedPrediction of Non-motor Symptoms in Fully Ambulatory MS Patients Using Vocal BiomarkersThe investigator will set up a study evaluating vocal biomarkers in people with MS in order to identify persons with non-motor symptoms: depression, cognitive deterioration, and…NCT05561621·Bern

CompletedUse of Two Deep Brain Stimulation (DBS) Electrodes to Treat Post-Traumatic TremorThe purpose of this research study is to: 1.NCT00954421·Gainesville, Florida

CompletedA Placebo Controlled Trial of Dalfampridine ER for Ambulatory Activity in People With Multiple SclerosisA randomized placebo controlled double-blind cross-over trial of Dalfampridine ER for effect on ambulatory activity in people with multiple sclerosisNCT01356940·Kirkland, Washington

RecruitingStudy to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple SclerosisThe purpose of this study is to evaluate the effectiveness, safety, tolerability, drug levels and drug effects of ozanimod compared to fingolimod in children and adolescents with…NCT06408259·Loma Linda, California and 32 others

CompletedImpact Study of 2 Therapeutic Strategy for Aggressive Remitting Multiple SclerosisCost-effectiveness study of 2 disease-modifying therapies (natalizumab versus mitoxantrone followed by immunomodulator) in the management of aggressive remitting multiple sclerosisNCT01065727·Brest and 1 other

Page 1 of 187Next